NCT02879136View on ClinicalTrials.gov

TAME-PD - Physical Therapy, Atomoxetine And, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Parkinson's Disease, Idiopathic
Interventions
DRUG

Methylphenidate

Patient will be randomized to Methylphenidate

OTHER

Physical Therapy

All Patients will have standard of care PT used for PD patients

DRUG

Atomoxetine

Patient will be randomized to Atomoxetine

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Hubert Fernandez

OTHER